On the same day that Sanofi and GSK announced the start of a new Phase 2 study of their delayed adjuvanted recombinant protein-based Covid-19 vaccine candidate, Sanofi...
20.04.2020
- The Paul Ehrlich Institute is the German federal institute for vaccines and biomedicines. Klaus Cichutek has been president of the research institution and medical regulatory body...
29.05.2019
- Chinese contract development and manufacturing organization (CDMO) WuXi Biologics has signed a Letter of Intent (LoI) with a “global vaccine leader” to construct a dedicated...
22.02.2019
- GlaxoSmithKline (GSK) Asia is selling subsidiary Chiron Behring Vaccines to Indian biotechnology company Bharat Biotech for an undisclosed sum. The all-cash transaction, which...
04.02.2018
- Lending fuel to the ongoing controversy in the Philippines over the possible side effects of Sanofi Pasteur 's Dengue vaccine Dengvaxia, an initial report by the Philippine General...
24.11.2017
- US immunology company Dynavax has finally secured approval from the US Food and Drug Administration (FDA) for its hepatitis B vaccine. Heplisav-B is the first new vaccine to be...
24.10.2017
- The US Food and Drug Administration on Oct. 20 approved Shingrix, the long awaited recombinant, adjuvant new shingles vaccine manufactured by UK drugmaker Glaxo SmithKline (GSK)...
23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
